Tag Directory / DIAGNOSTICS     showing 1–4 of 4   RSS


for: Saturday, August 08, 2026



How a Deadly Superbug Tricks the Immune System to Survive in Hair Follicles

discovermagazine - Learn how Candida auris takes advantage of the skin’s immune response to stay put inside hair follicles.

AI Summary: Researchers show that Candida auris can persist in hair follicles by rewiring local skin immune responses, creating a hidden reservoir that helps the fungus survive disinfection and spread in healthcare settings. The finding explains persistent colonization and suggests new diagnostic and decolonization strategies focused on follicular niches — because apparently this pathogen likes a good hairdo.

17 days / medicalxpress

23 days / medicalxpress




FDA Approved Pluvicto Plus ARPI for PSMA-Positive mAPMN/S Prostate Cancer

oncodaily - On July 31, 2026, the US Food and Drug Administration approved lutetium Lu 177 vipivotide tetraxetan, marketed as Pluvicto, in combination with androgen receptor pathway inhibitor (ARPI) therapy for adults […]

AI Summary: The FDA has approved an expanded use for a lutetium‑177 radiopharmaceutical (Pluvicto), broadening access for PSMA‑positive metastatic prostate cancer patients and potentially speeding the adoption of targeted radionuclide therapy. Clinicians note the approval could shift treatment sequencing and patient pathways, with implementation details and eligibility criteria guiding real‑world impact.


Access, dose optimization and real-world data for Lu-177

13 days / oncodaily

13 days / oncodaily

14 days / oncodaily

16 days / oncodaily


FDA expands Pluvicto approval; industry reaction

18 days / oncodaily

23 days / oncodaily

25 days / oncodaily


PSMAddition trial: earlier Lu-177 delays metastatic progression

9 days / oncodaily

13 days / esmo

18 days / oncodaily

21 days / oncodaily

22 days / medicalxpress




NCCS Develops AI Tool to Predict Liver Cancer Recurrence After Surgery

oncodaily - National Cancer Centre Singapore (NCCS) shared on LinkedIn: “Can we now predict who’s at greatest risk for liver cancer recurrence? Congratulations to NCCS’ Professor Pierce Chow, Associate Professor Wai Leong Tam, Mr. Karthik Sekar, […]

AI Summary: A newly developed AI model predicts risk of liver cancer recurrence following surgical resection, integrating imaging and clinical variables to stratify patients more accurately. Early validation suggests the tool could personalize surveillance intensity and adjuvant therapy decisions, reducing unnecessary exams for low‑risk patients while focusing resources where recurrence risk is highest.

13 days / oncodaily

23 days / oncodaily

26 days / medicalxpress




Some COVID-19 Patients Suffered Heart Damage, an Overlooked Coronavirus Protein May Explain Why

discovermagazine - Discover how the inconspicuous nucleocapsid protein from coronaviruses can trigger hyperinflammation, an effect not typically seen in other viruses.

AI Summary: Scientists identified a previously underappreciated SARS‑CoV‑2 protein that appears to damage heart tissue and may help explain persistent post‑COVID symptoms. The study ties the viral molecule to mechanisms of cardiac injury, opening diagnostic and therapeutic research paths for long COVID cardiac effects — proof that sometimes the troublemaker was hiding in plain sight.

16 days / medicalxpress

18 days / medicalxpress

24 days / medicalxpress




Back to Top


DIAGNOSTICS Heatmap


90 days, weeks are vertical, left is older; hover for info, click to see that day's coverage.


StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try FDA, Venture Capital, None, Vitamin D and look for the RSS link.


NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.